The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?
Paulo A F Pacheco1, Robson X Faria1
1Laboratório de Toxoplasmose e outras Protozooses, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Abstract:
Coronavirus disease 2019 (COVID-19) pathogenesis remains under investigation. Growing evidence indicates the establishment of a hyperinflammatory response, characterized by sustained production of cytokines, such as IL-1β. The release and maturation of this cytokine are dependent on the activation of a catalytic multiprotein complex, known as "inflammasome". The most investigated is the NLRP3 inflammasome, which can be activated by various stimuli, such as the recognition of extracellular ATP by the P2X7 receptor. Based on the recent literature, we present evidence that supports the idea that the P2X7R/NLRP3 axis may be involved in the immune dysregulation caused by the SARS-CoV-2 infection.
Insights
The P2X7 receptor/NLRP3 inflammasome axis may drive immune dysregulation in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, contributing to COVID-19 pathogenesis through sustained cytokine production.
Area of Science:
- Immunology
- Pathogenesis
- Molecular Biology
Background:
- Coronavirus disease 2019 (COVID-19) pathogenesis involves immune system dysregulation.
- Hyperinflammation, marked by sustained cytokine production like IL-1β, is a key feature.
- Cytokine release and maturation depend on inflammasome activation, particularly NLRP3.
Purpose of the Study:
- To explore the potential role of the P2X7 receptor/NLRP3 inflammasome axis in SARS-CoV-2 infection.
- To investigate the link between P2X7R/NLRP3 activation and COVID-19 immune dysregulation.
Main Methods:
- Literature review and evidence synthesis.
- Analysis of molecular mechanisms underlying inflammasome activation.
- Correlation of P2X7R/NLRP3 pathway with SARS-CoV-2 infection characteristics.
Main Results:
- The P2X7 receptor (P2X7R) can be activated by extracellular ATP.
- NLRP3 inflammasome activation, triggered by P2X7R, leads to IL-1β maturation and release.
- Evidence suggests this axis contributes to the hyperinflammatory response observed in SARS-CoV-2 infections.
Conclusions:
- The P2X7R/NLRP3 inflammasome pathway is a potential driver of immune dysregulation in COVID-19.
- Targeting this axis could offer therapeutic strategies for managing SARS-CoV-2-induced hyperinflammation.
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCRs Regulate Adenylyl Cylase Activity


